Counterfeit Drug Prevention Act of 2007

Deficit Reduction Act and implementing regulations focusing on Medicaid Reform; H.R.780 - Counterfeit Drug Prevention Act of 2007.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act

Client expense: $3,070,000 · Firm income: Not reported

HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07

Client expense: $3,070,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)

Deficit Reduction Act and implementing regulations focusing on Medicaid Reform; H.R. 780 -- Counterfeit Drug Prevention Act of 2007. H.R. 5839 -- Safeguarding America's Pharmaceuticals Act of 2008.

Client expense: $261,875 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.5839, Safeguarding America's Pharmaceuticals Act S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008

Client expense: $205,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07

Client expense: $3,060,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act

Client expense: $3,060,000 · Firm income: Not reported

Deficit Reduction Act and implementing regulations focusing on Medicaid Reform; H.R.780 - Counterfeit Drug Prevention Act of 2007.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008

Client expense: Not reported · Firm income: $30,000

Deficit Reduction Act and implementin regulations focusing on Medicaid Reform; H.R. 780 -- Counterfeit Drug Prevention Act of 2007

Client expense: $261,875 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, SENATE

HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07

Client expense: $3,060,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act

Client expense: $3,060,000 · Firm income: Not reported

S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 S. 980, Online Pharmacy Consumer Protection Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 S. 1951, Fair Medicaid Drug Payment Act of 2007 H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007

Client expense: $205,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Deficit Reduction Act and implementing regulations focusing on Medicaid Reform; H.R.780 - Counterfeit Drug Prevention Act of 2007.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 S. 980, Online Pharmacy Consumer Protection Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 S. 1951, Fair Medicaid Drug Payment Act of 2007 H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007

Client expense: Not reported · Firm income: $30,000

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 445, Patent Reform Act HR 1908, Patent Reform Act S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act

Client expense: $2,800,000 · Firm income: Not reported

HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07

Client expense: $2,800,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)

S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 S. 980, Online Pharmacy Consumer Protection Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 S. 1951, Fair Medicaid Drug Payment Act of 2007 H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 S. 207, Combat Methamphetamine Enhancement Act of 2007

Client expense: $155,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Deficit Reduction Act and implementing regulations focusing on Medicaid Reform; H.R.780 - Counterfeit Drug Prevention Act of 2007.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Deficit Reduction Act and implementing regulations focusing on Medicaid Reform; H.R. 780 -- Counterfeit Drug Prevention Act of 2007

Client expense: $261,875 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 S. 980, Online Pharmacy Consumer Protection Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 S. 1951, Fair Medicaid Drug Payment Act of 2007 H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 S. 207, Combat Methamphetamine Enhancement Act of 2007

Client expense: Not reported · Firm income: $20,000

S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 S. 980, Online Pharmacy Consumer Protection Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 S. 1951, Fair Medicaid Drug Payment Act of 2007 H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 S. 207, Combat Methamphetamine Enhancement Act of 2007

Client expense: Not reported · Firm income: $20,000

HR 1908 Patent Reform Act of 2007 HR 5055 To amend title 17, United States Code, to provide protection for fashion design H.R. 5156 Counterfeit Drug Prevention Act of 2006 S 522 Intellectual Property Rights Enforcement Act S 1145 Patent Reform Act of 2007 HR 34 Pilot Program in Certain District Courts HR 780 Counterfeit Drug Prevention Act of 2007 HR 1689 To provide support to combat illegal downloading on college and university campuses HR 3578 - Intellectual Property Rights Enforcement Act S 2317 - Intellectual Property Enforcement Act of 2007 HR 4279 - Prioritizing Resources and Organization for Intellectual Property Act of 2007 HR 4175 - Privacy and Cybercrime Enforcement Act of 2007

Client expense: $19,060,000 · Firm income: Not reported

H.R. 3610, "The Food and Drug Import Safety Act of 2007" and other possible import-safety related legislation stemming from a series of high profile product recalls. HR 1525 Internet Spyware (I-SPY) Prevention Act of 2007 HR 964 Spy Act HR 948 Social Security Number Protection Act of 2007 H.R. 5156 Counterfeit Drug Prevention Act of 2006 S 522 Intellectual Property Rights Enforcement Act S. 495 Personal Data Privacy and Security Act of 2007 S. 1178 Identity Theft Prevention Act S. 522 Intellectual Property Rights Enforcement Act H.R. 780 Counterfeit Drug Prevention Act of 2007 S. 1780 Protecting Children From Indecent Programming Act H.R. 4008 Credit and Debit Card Receipt Clarification Act of 2007 S. 2168 Identity Theft Enforcement and Restitution Act of 2007 H.R. 3541 Do-Not-Call Improvement Act of 2007 H.R. 3578 Intellectual Property Rights Enforcement Act S. 2317 Intellectual Property Enforcement Act of 2007 H.R. 4279 Prioritizing Resources and Organization for Intellectual Property Act of 2007 H.R. 4175 Privacy and Cybercrime Enforcement Act of 2007 S. 242 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 853 Wellness and Prevention Act 2007 S. 358 / H.R. 493 Genetic Information Nondiscrimination Act of 2007 S. 1019 Universal Health Care Choice and Access Act H.R. 1046 Medicare Quality Improvement Organization Modernization Act of 2007 H.R. 2580 Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2007 H.R. 1666 Health Care price Transparency Promotion Act

Client expense: $19,060,000 · Firm income: Not reported

S. 215, Internet Freedom Preservation Act S. 2302, Food, Energy and Security Act of 2007, all provisions relating to broadband H.R. 2419, Farm, Nutrition, and Bioenergy Act of 2007, all provisions relating to broadband Net Neutrality HR 1525 Internet Spyware (I-SPY) Prevention Act of 2007 HR 964 Spy Act HR 743 Permanent Internet Tax Freedom Act of 2007 HR 948 Social Security Number Protection Act of 2007 HR 1908 Patent Reform Act of 2007 HR 5055 To amend title 17, United States Code, to provide provide protection for fashion design H.R. 5156 Counterfeit Drug Prevention Act of 2006 S 522 Intellectual Property Rights Enforcement Act S 495 Personal Data Privacy and Security Act of 2007 S 1178 Identity Theft Prevention Act S 156 Permanent Internet Tax Freedom Act of 2007 S 1145 Patent Reform Act of 2007 S 761 America Creating Opportunities to Meaningfully Promote Excellence in Technology, Education, and Science Act HR 34 Pilot Program in Certain District Courts HR 780 Counterfeit Drug Prevention Act of 2007 HR 1689 To provide support to combat illegal downloading on college and university campuses HR 4175 - Privacy and Cybercrime Enforcement Act of 2007 HR 4279 - Prioritizing Resources and Organization for Intellectual Property Act of 2007 S 2317 - Intellectual Property Enforcement Act of 2007 HR 3578 - Intellectual Property Rights Enforcement Act HR 3541 - Do-Not-Call Improvement Act of 2007 S 2168 - Identity Theft Enforcement and Restitution Act of 2007 HR 275 - Global Online Freedom Act of 2007 HR 4008 - Credit and Debit Card Receipt Clarification Act of 2007 S 1780 - Protecting Children from Indecent Programming Act S 1492 - Broadband Data Improvement Act S 1190 - Connect The Nation Act

Client expense: $19,060,000 · Firm income: Not reported

S. 215, Internet Freedom Preservation Act S. 2302, Food, Energy and Security Act of 2007, all provisions relating to broadband H.R. 2419, Farm, Nutrition, and Bioenergy Act of 2007, all provisions relating to broadband Net Neutrality HR 1525 Internet Spyware (I-SPY) Prevention Act of 2007 HR 964 Spy Act HR 743 Permanent Internet Tax Freedom Act of 2007 HR 948 Social Security Number Protection Act of 2007 HR 1908 Patent Reform Act of 2007 HR 5055 To amend title 17, United States Code, to provide provide protection for fashion design H.R. 5156 Counterfeit Drug Prevention Act of 2006 S 522 Intellectual Property Rights Enforcement Act S 495 Personal Data Privacy and Security Act of 2007 S 1178 Identity Theft Prevention Act S 156 Permanent Internet Tax Freedom Act of 2007 S 1145 Patent Reform Act of 2007 S 761 America Creating Opportunities to Meaningfully Promote Excellence in Technology, Education, and Science Act HR 34 Pilot Program in Certain District Courts HR 780 Counterfeit Drug Prevention Act of 2007 HR 1689 To provide support to combat illegal downloading on college and university campuses HR 4175 - Privacy and Cybercrime Enforcement Act of 2007 HR 4279 - Prioritizing Resources and Organization for Intellectual Property Act of 2007 S 2317 - Intellectual Property Enforcement Act of 2007 HR 3578 - Intellectual Property Rights Enforcement Act HR 3541 - Do-Not-Call Improvement Act of 2007 S 2168 - Identity Theft Enforcement and Restitution Act of 2007 HR 275 - Global Online Freedom Act of 2007 HR 4008 - Credit and Debit Card Receipt Clarification Act of 2007 S 1780 - Protecting Children from Indecent Programming Act S 1492 - Broadband Data Improvement Act S 1190 - Connect The Nation Act

Client expense: $19,060,000 · Firm income: Not reported

HR 1908 Patent Reform Act of 2007 HR 5055 To amend title 17, United States Code, to provide protection for fashion design H.R. 5156 Counterfeit Drug Prevention Act of 2006 S 522 Intellectual Property Rights Enforcement Act S 1145 Patent Reform Act of 2007 HR 34 Pilot Program in Certain District Courts HR 780 Counterfeit Drug Prevention Act of 2007 HR 1689 To provide support to combat illegal downloading on college and university campuses HR 3578 - Intellectual Property Rights Enforcement Act S 2317 - Intellectual Property Enforcement Act of 2007 HR 4279 - Prioritizing Resources and Organization for Intellectual Property Act of 2007 HR 4175 - Privacy and Cybercrime Enforcement Act of 2007

Client expense: $19,060,000 · Firm income: Not reported

H.R. 3610, "The Food and Drug Import Safety Act of 2007" and other possible import-safety related legislation stemming from a series of high profile product recalls. HR 1525 Internet Spyware (I-SPY) Prevention Act of 2007 HR 964 Spy Act HR 948 Social Security Number Protection Act of 2007 H.R. 5156 Counterfeit Drug Prevention Act of 2006 S 522 Intellectual Property Rights Enforcement Act S. 495 Personal Data Privacy and Security Act of 2007 S. 1178 Identity Theft Prevention Act S. 522 Intellectual Property Rights Enforcement Act H.R. 780 Counterfeit Drug Prevention Act of 2007 S. 1780 Protecting Children From Indecent Programming Act H.R. 4008 Credit and Debit Card Receipt Clarification Act of 2007 S. 2168 Identity Theft Enforcement and Restitution Act of 2007 H.R. 3541 Do-Not-Call Improvement Act of 2007 H.R. 3578 Intellectual Property Rights Enforcement Act S. 2317 Intellectual Property Enforcement Act of 2007 H.R. 4279 Prioritizing Resources and Organization for Intellectual Property Act of 2007 H.R. 4175 Privacy and Cybercrime Enforcement Act of 2007 S. 242 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 853 Wellness and Prevention Act 2007 S. 358 / H.R. 493 Genetic Information Nondiscrimination Act of 2007 S. 1019 Universal Health Care Choice and Access Act H.R. 1046 Medicare Quality Improvement Organization Modernization Act of 2007 H.R. 2580 Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2007 H.R. 1666 Health Care price Transparency Promotion Act

Client expense: $19,060,000 · Firm income: Not reported

Deficit Reduction Act and implementing regulations focusing on Medicaid Reform; H.R.780 - Counterfeit Drug Prevention Act of 2007.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Deficit Reduction Act and implementing regulations focusing on Medicaid Reform; HR 780 Counterfeit Drug Prevention Act of 2007

Client expense: $523,750 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Generic Biologics - S.623, S.1695, H.R.1038, and H.R.1956 Pediatric Exclusivity - S.1082, H.R.2900, and H.R.3580 Drug Safety - S.484, S.1082, H.R.3580 Authorized Generics - S.438 and H.R.806 Citizen Petitions - S.1088, S.25, and H.R.3580 Import Safety - H.R.3610 Counterfeit Drugs - S.242, S.1082, H.R.780, H.R.2710, H.R.3580, and H.R.3610

Client expense: $398,128 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

Client expense: $7,220,000 · Firm income: Not reported

Generic Biologics - S.623, S.1695, H.R. 1038, and H.R. 1956 Pediatric Exclusivity - S.1082 and H.R. 2900 Drug Safety - S.484 and S.1082 Authorized Generics - S.438 and H.R. 806 Citizen Petitions - S.1088 and S.25 Counterfeit Drugs - S.242, S.1082, H.R. 780 and H.R.2710

Client expense: $420,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)

Deficit Reduction act and implementing regulations focusing on Medicaid Reform; H.R. 780 - Counterfeit Drug Prevention Act of 2007.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1165, Swift Approval, Full Evaluation Drug Act of the "SAFE Drug Act"; (Provisions relating to drug safety.) H.R. 970, Gang Prevention and Effective Deterrence Act of 2005; (Provisions relating to bulk distribution of DXM) H.R. 780, The "Counterfeit Drug Prevention Act of 2007"; (Provisions relating to prevention of counterfeit drugs.)

Client expense: $2,082,850 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

* H.R. 1908/S. 1145, Patent Reform Act; (Provisions relating to modernize and harmonize the U.S. process for patent review and approvals.) S. 316, Preserve Access to Affordable Generics Act (Provisions relating to patent settlements.) S. 438, Fair Prescription Drug Competition Act of 2007; (Sections relating to authorized generics.) H.R. 1038, Access to Life-Saving Medicine Act (provisions relating to follow-on biologics.) H.R. 780, Counterfeit Drug Prevention Act of 2007 (Provisions relating to prevention of counterfeit drugs.) H.R. 1908/S. 1145, A bill to amend title 35, United States Code to provide for patent reform; (Provisions relating to patent reform.) H.R. 1908/S. 1145, A bill to amend title 35, United States Code, to provide for patent reform; (Provisions relating to patent reform.) 7 16 24

Client expense: $2,082,850 · Firm income: Not reported

* H.R. 1232/S. 746, To establish a competitive grant program to build capacity in veterinary medical education and expand the workforce of veterinarians engaged in public health practice and biomedical research; Section 2. Competitive Grants; (Provisions relating to entire bill.) S. 438, Fair Prescription Drug Competition Act of 2007; (Sections relating to authorized generics.) H.R. Access to Life -Saving Medicine Act; (Relating to follow-on biologics) H.R. 1165, Swift Approval, Full Evaluation Drug Act of the "SAFE Drug Act"; (Provisions relating to drug safety.) S. 21, A bill to provide for homeland security grant coordination and simplification, and for other purposes; (Sections relating to access to women's health therapies.) H.R. 970, Gang Prevention and Effective Deterrence Act of 2005; (Relating to bulk distribution of DXM.) H.R. 780, Counterfeit Drug Prevention Act of 2007; (Relating to prevention of counterfeit drugs.) H.R. 1282, Medigap Access Improvement Act; (Provisions relating to MediGap and hemophilia patients.) S. 1082, Prescription Drug User Fee Amendments of 2007; (Relating to FDA user fees reauthorization.) Full House Energy & Commerce Committee Markup of Committee prints on: PDUFA, MDUFMA, PREA, BPCA, Drug Safety; (Relating to reauthorization fo FDA user fees and safety.) H.R. 4, Prescription Drug Negotiation Act of 2007; (Provisions concerning repealing non-interference in Medicare.) S. 316, the "Preserve Access to Affordable Generics Act"; (Provisions relating to patent settlements.) 15

Client expense: $2,082,850 · Firm income: Not reported

S 1145 Patent Reform Act of 2007 HR 34 Pilot Program in Certain District Courts HR 780 Counterfeit Drug Prevention Act of 2007 HR 1689 To provide support to combat illegal downloading on college and university campuses HR 1908 Patent Reform Act of 2007 HR 5055 To amend title 17, United States Code, to provide provide protection for fashion design H.R. 5156 Counterfeit Drug Prevention Act of 2006 S 522 Intellectual Property Rights Enforcement Act

Client expense: $11,780,000 · Firm income: Not reported

S. 215, Internet Freedom Preservation Act Net Neutrality Copper Retirement HR 1525 Internet Spyware (I-SPY) Prevention Act of 2007 HR 964 Spy Act HR 743 Permanent Internet Tax Freedom Act of 2007 HR 948 Social Security Number Protection Act of 2007 HR 1908 Patent Reform Act of 2007 HR 5055 To amend title 17, United States Code, to provide protection for fashion design H.R. 5156 Counterfeit Drug Prevention Act of 2006 S 522 Intellectual Property Rights Enforcement Act S 495 Personal Data Privacy and Security Act of 2007 S 1178 Identity Theft Prevention Act S 156 Permanent Internet Tax Freedom Act of 2007 S 1145 Patent Reform Act of 2007 S 761 America Creating Opportunities to Meaningfully Promote Excellence in Technology, Education, and Science Act HR 34 Pilot Program in Certain District Courts HR 780 Counterfeit Drug Prevention Act of 2007 HR 1689 To provide support to combat illegal downloading on college and university campuses

Client expense: $11,780,000 · Firm income: Not reported

H.R. 964, Securely Protect Yourself Against Cyber Trespass Act S. 1178, Identity Theft Prevention Act H.R. 1525, Internet Spyware Prevention Act of 2007 H.R. 1721, Pool and Spa Safety Act S.1019 Universal Health Care Choice and Access Act H.R. 1046 Medicare Quality Improvement Organization Modernization Act of 2007 H.R.2580 Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2007 H.R.1666 Health Care Price Transparency Promotion Act S. 242 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 853 Wellness and Prevention Act 2007 S. 358 Genetic Information Nondiscrimination Act of 2007 H.R. 493 Genetic Information Nondiscrimination Act of 2007 HR 1525 Internet Spyware (I-SPY) Prevention Act of 2007 HR 964 Spy Act HR 948 Social Security Number Protection Act of 2007 H.R. 5156 Counterfeit Drug Prevention Act of 2006 S 495 Personal Data Privacy and Security Act of 2007 S 1178 Identity Theft Prevention Act S 522 Intellectual Property Rights Enforcement Act H.R. 780 Counterfeit Drug Prevention Act of 2007 H.R. 2474, a bill to increase the maximum Civil Penalty for Violations of the Consumer Product Safety Act.

Client expense: $11,780,000 · Firm income: Not reported